A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/01/2004	EP1480626A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
12/01/2004	EP1480624A2 Pharmaceutical tablet
12/01/2004	EP1480623A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
12/01/2004	EP1480621A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
12/01/2004	EP1480620A2 (ester)-lysolecithins in liposomes
12/01/2004	EP1480618A1 Sustained release drug formulations containing a carrier peptide
12/01/2004	EP1480617A2 Pressurised metered dose inhalers containing solutions of beta-2 agonists
12/01/2004	EP1480616A1 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
12/01/2004	EP1480615A1 Formoterol superfine formulation
12/01/2004	EP1480613A1 Jojoba product for reducing weight, blood lipid levels and for the prevention and treatment of cancer
12/01/2004	EP1480609A1 Whitening cosmetic composition
12/01/2004	EP1480603A1 Use of sugar esters in cosmetic and/or pharmaceutical preparations
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480595A2 Use of esters of long-chain fatty acids for treatment of autoimmune diseases
12/01/2004	EP1480521A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/01/2004	EP1480517A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
12/01/2004	EP1399448B1 Imidazo 1,5-a] pyrimido 5,4-d] benzazepine derivatives as gaba a receptor modulators
12/01/2004	EP1368352B1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
12/01/2004	EP1358180B1 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/01/2004	EP1317188B1 Use of benzophenanthridine alkaloids as feed additives
12/01/2004	EP1280522B1 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
12/01/2004	EP1263761B1 Compounds for pdt
12/01/2004	EP1261355B1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP1214093B1 Method for producing a tablet made of isomaltulose, isomalt or isomalt variants and corresponding products
12/01/2004	EP1212428B1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression
12/01/2004	EP1196383B1 Process for preparing amlodipine benzenesulphonate
12/01/2004	EP1189631B1 Neurodegenerative disorder related gene
12/01/2004	EP1185539B1 Organosilyl compounds having nuclear hormone receptor modulating activity
12/01/2004	EP1176975A4 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
12/01/2004	EP1175408B1 Pyrimidinone compounds
12/01/2004	EP1173403B1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
12/01/2004	EP1158953B1 Aerosol hair spray compositions comprising combinations of silicone-grafted copolymers
12/01/2004	EP1156037B1 Chondrongenesis promotors and indolin-2-one derivatives
12/01/2004	EP1117388A4 Antioxidant gel for gingival conditions
12/01/2004	EP1104407B1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors
12/01/2004	EP1100778B1 Oxidised sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
12/01/2004	EP1075264B1 New drug combinations of reboxetine and pindolol
12/01/2004	EP1056462A4 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
12/01/2004	EP1044688B1 Method for solubilizing pyridonecarboxylic acids and aqueous solutions containing pyridonecarboxylic acids
12/01/2004	EP1012180B1 Hepatitis c inhibitor peptide analogues
12/01/2004	EP0994697B1 Rapamycin formulations for oral administration
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0966974B1 Antibacterial composition for topical administration containing faropenem
12/01/2004	EP0961610B1 Skin preparation
12/01/2004	EP0930076B1 Pharmaceutical compositions comprising CS-866 and insulin resistance improving agents and their use for the treatment of arteriosclerosis and xanthoma
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	EP0852501B1 Use of hyaluronic acid as an immunosuppressant
12/01/2004	EP0808316B9 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
12/01/2004	EP0625905B1 Composition containing body activated fragrance for contacting the skin and method of use
12/01/2004	CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
12/01/2004	CN1551884A Thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity
12/01/2004	CN1551883A Glycine-substituted thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity
12/01/2004	CN1551882A Novel anticonvulsant derivative salts
12/01/2004	CN1551881A Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
12/01/2004	CN1551880A Crystalline forms of valacyclovir hydrochloride
12/01/2004	CN1551879A Stable polymorph of FLIBANSERIN, technical process for its preparation and the use thereof for preparing medicaments
12/01/2004	CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/01/2004	CN1551877A Piperidine derivatives useful as CCR5 antagonists
12/01/2004	CN1551872A Biologically active methylene blue derivatives
12/01/2004	CN1551871A Process for preparinga thiazole PPAR-ligand and polymorphs thereof
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551789A Single dose aromatase inhibitor for treating infertility
12/01/2004	CN1551784A Prostaglandin compositions and methods of treatment for male erectile dysfunction
12/01/2004	CN1551778A Pharmaceutical composition for diabetic neuropathy
12/01/2004	CN1551777A Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
12/01/2004	CN1551776A Method of treatment of type I diabetes
12/01/2004	CN1551775A Remedies for retina and choroid diseases containing steroids as the active ingredient
12/01/2004	CN1551774A Emergency contraceptive medicinal dose formula and medicinal composition
12/01/2004	CN1551773A Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
12/01/2004	CN1551772A Inhibition of the growth factor dependency of tumor cells
12/01/2004	CN1551771A Method and composition for treatment of cancer
12/01/2004	CN1551770A Sustained release formulations of oxymorphone
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551768A Substituted benzimidazole dosage forms and method of using same
12/01/2004	CN1551767A Cancer treatment
12/01/2004	CN1551766A Lymphocytic activation inhibitor and remedial agent for autoimmune disease
12/01/2004	CN1551765A Methods and materials for the treatment of testosterone deficiency in men
12/01/2004	CN1551764A Medicinal composition containing gamma-tributyrobetaine
12/01/2004	CN1551763A Novel treatment method
12/01/2004	CN1551762A Valproic acid derivatives for the treatment of pain.
12/01/2004	CN1550550A Oncogene, recombinant protein derived therefrom, and uses thereof
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1550233A Skin patch and method for administering testosterone
12/01/2004	CN1550232A Use of heterocyclic amide in production of autoimmune diseases inhibitors
12/01/2004	CN1550231A Method and compositions for administering taxanes orally to human patients
12/01/2004	CN1550230A Pharmaceutical solid preparation containing a poorly soluble drug and production process thereof
12/01/2004	CN1550160A Alkaline mineral matter solution ,its preparation method and food for preventing osteoporosis using it
12/01/2004	CN1550137A Two-and three-component fungicidal mixtures
12/01/2004	CN1177865C Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
12/01/2004	CN1177861C Macrocylic peptides active against the hepatitis V virus
12/01/2004	CN1177860C Cholenic acid amides and pharmaceutical compositions thereof
12/01/2004	CN1177858C Beta, beta-disubstituted derivatives of 9-deoxo-9a-N-ethenyl-9a-N-ethenyl-9a-homoerythromycin A
12/01/2004	CN1177857C Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
12/01/2004	CN1177855C Carbohydrate derivatives
12/01/2004	CN1177852C Phosphonic diester derivatives
12/01/2004	CN1177850C Camptothecin analogs and methods of preparation thereof
12/01/2004	CN1177848C Bicyclic heteroaromatic compounds useful as LH agonists

1 ... 4875 4876 4877 4878 4879 4880 4881 4882 4883 4884 4885 4886 4887 4888 4889 4890 4891 4892 4893 4894 4895 ... 7860